FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Macleods Pharma Clopidogrel Tablets Recall

Clopidogrel Tablets, USP, 75 mg, 500-count bottle, Rx only, Manufactured for: Macleods…

Macleods Pharma Usa Inc · Plainsboro, NJ

Risk level
Class II
Reported by FDA
Sep 8, 2021
Recall ID
D-0787-2021
Check your lot numberHow we source this data

Summary

Macleods Pharma recalled Clopidogrel Tablets starting Aug 2, 2021. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0787-2021 on Sep 8, 2021. Reason: Presence of foreign matter. Status: Terminated.

Why it was recalled

Presence of foreign matter

Product description

Clopidogrel Tablets, USP, 75 mg, 500-count bottle, Rx only, Manufactured for: Macleods Pharma USA, Inc., Plainsboro, NJ 08536, Manufactured by: Macleods Pharmaceutical Ltd., Baddi, Himachal, Pradesh, INDIA NDC 33342-060-15

Lot numbers, UPCs & expiration codes

Lot # BCA82021A, Exp 06/2023

Where it was sold

Product was distributed nationwide.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0787-2021
Classification
Class II
Status
Terminated
Recall initiated
Aug 2, 2021
FDA report date
Sep 8, 2021
Quantity
444,000 tablets / 888 unit packs of 500 count
Recall type
Voluntary: Firm initiated
Recalling firm
Macleods Pharma Usa Inc

Original FDA data

Every field from FDA enforcement report D-0787-2021, exactly as published.

Show all FDA fields
City
Plainsboro
State
NJ
Status
Terminated
Country
United States
Event ID
88391
Address
666 Plainsboro Rd Bldg 200 Ste 230
Code information
Lot # BCA82021A, Exp 06/2023
Postal code
08536-0009
Report date
Sep 8, 2021
Product type
Drugs
Recall number
D-0787-2021
Classification
Class II
Recalling firm
Macleods Pharma Usa Inc
Product quantity
444,000 tablets / 888 unit packs of 500 count
Termination date
Dec 2, 2022
Reason for recall
Presence of foreign matter
Voluntary / mandated
Voluntary: Firm initiated
Product description
Clopidogrel Tablets, USP, 75 mg, 500-count bottle, Rx only, Manufactured for: Macleods Pharma USA, Inc., Plainsboro, NJ 08536, Manufactured by: Macleods Pharmaceutical Ltd., Baddi, Himachal, Pradesh, INDIA NDC 33342-060-15
Distribution pattern
Product was distributed nationwide.
Recall initiation date
Aug 2, 2021
Initial firm notification
Letter
Center classification date
Aug 31, 2021

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0787-2021, published Sep 8, 2021. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls